Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

94 Live Marks
192 on record
Corp.
First Filed:Nov 14, 1989Latest Filed:Oct 15, 2026Address:50 Northern Avenue, Boston, MA 02210, US

Portfolio Overview

Previous
4

Top Classes

Class 5
Pharmaceuticals
144(75%)
Class 44
Medical, beauty and agricultural services
32(17%)
Class 42
Software, IT Services & Scientific Research
18(9%)

TTAB Proceedings

Proceedings
34
As Plaintiff
32(94%)
As Defendant
2(6%)
Extensions of Time
35

Top Firms

Loading...

Trademark Activity Timeline(1989 – 2026)

Trademark Portfolio

196 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
AMPOZEOS
AMPOZEOS
Trademark
Word
PENDING
Owner:
Serial:50163235
Filed:Oct 15, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
BAMPOVIOS
BAMPOVIOS
Trademark
Word
PENDING
Owner:
Serial:50163241
Filed:Oct 15, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
BELMODICO
BELMODICO
Trademark
Word
PENDING
Owner:
Serial:50163251
Filed:Oct 15, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
UPOBA
UPOBA
Trademark
Word
PENDING
Owner:
Serial:50163254
Filed:Oct 15, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
YURPOVI
YURPOVI
Trademark
Word
PENDING
Owner:
Serial:50163259
Filed:Oct 15, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
THE POVTENZI TRIFECTA
THE POVTENZI TRIFECTA
Service Mark
Word
PENDING
Owner:
Serial:50073326
Filed:Aug 26, 2026
Classes:44
Description: Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications in the nature of providing information about healthcare
POVTENZI + YOU
POVTENZI + YOU
Service Mark
Word
PENDING
Owner:
Serial:99799399
Filed:May 1, 2026
Classes:44
Description: Providing health information to patients, caregivers and healthcare professionals; providing healthcare information; Providing healthcare information, namely, providing healthcare information about medications for patient education and for patient support
POVTENZI
POVTENZI
Trademark
Combined
PENDING
Owner:
Serial:99779444
Filed:Apr 22, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
POVTENZI
POVTENZI
Trademark
Combined
PENDING
Owner:
Serial:99714539
Filed:Mar 20, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
VYKAFTY
VYKAFTY
Trademark
Word
PENDING
Owner:
Serial:99685511
Filed:Mar 5, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of cystic fibrosis
INFORMEDPAINCARE
INFORMEDPAINCARE
Service Mark
Word
PENDING
Owner:
Serial:99560709
Filed:Dec 22, 2025
Classes:44
Description: Telehealth and telemedicine services
INFORMED PAIN CARE
INFORMED PAIN CARE
Service Mark
Word
PENDING
Owner:
Serial:99553291
Filed:Dec 17, 2025
Classes:44
Description: Telehealth and telemedicine services
99518157
99518157
Trademark
Design
PENDING
Owner:
Serial:99518157
Filed:Nov 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
99518171
99518171
Trademark
Design
PENDING
Owner:
Serial:99518171
Filed:Nov 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
DONDE EMPIEZA EL DOLOR COMIENZA JOURNAVX
DONDE EMPIEZA EL DOLOR COMIENZA JOURNAVX
Service Mark
Word
PENDING
Owner:
Serial:99377064
Filed:Sep 5, 2025
Classes:35, 44
Description: Class 35: Providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals
Class 44: Providing medical information, namely, information regarding medical conditions, treatments to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
HABLEMOS SOBRE EL DOLOR
HABLEMOS SOBRE EL DOLOR
Service Mark
Word
PENDING
Owner:
Serial:99376556
Filed:Sep 5, 2025
Classes:44
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare; providing health information in the field of acute pain management
ISLEKEY
ISLEKEY
Trademark
Word
PENDING
Owner:
Serial:99376563
Filed:Sep 5, 2025
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
NAVIGATING PAIN PATHWAYS
NAVIGATING PAIN PATHWAYS
Service Mark
Word
PENDING
Owner:
Serial:99376538
Filed:Sep 5, 2025
Classes:44
Description: Providing medical information; Providing medical information in the field of pain treatments
TALK ABOUT PAIN LIVE
TALK ABOUT PAIN LIVE
Service Mark
Word
REGISTERED
Owner:
Serial:99376550
Filed:Sep 5, 2025
Classes:44
Registration:8473725
Registered:Sep 29, 2026
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare; providing health information in the field of acute pain management
AMPOVIOS
AMPOVIOS
Trademark
Word
PENDING
Owner:
Serial:99250876
Filed:Jun 24, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
BYPOVY
BYPOVY
Trademark
Word
PENDING
Owner:
Serial:99250874
Filed:Jun 24, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
POVTENZI
POVTENZI
Trademark
Word
PENDING
Owner:
Serial:99250865
Filed:Jun 24, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
MYTDTFUTURE
MYTDTFUTURE
Service Mark
Word
REGISTERED
Owner:
Serial:99187713
Filed:May 15, 2025
Classes:44
Registration:8384655
Registered:Aug 4, 2026
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services in the nature of providing health information in the field of blood disorders; providing health information in the field of blood disorders
TODAY DETERMINES TOMORROW
TODAY DETERMINES TOMORROW
Service Mark
Word
REGISTERED
Owner:
Serial:99187709
Filed:May 15, 2025
Classes:44
Registration:8277849
Registered:May 26, 2026
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services in the nature of providing health information in the field of blood disorders; providing health information in the field of blood disorders
POWER FORWARD
POWER FORWARD
Service Mark
Word
REGISTERED
Owner:
Serial:99166138
Filed:May 1, 2025
Classes:44
Registration:7985762
Registered:Oct 14, 2025
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services in the nature of providing health information in the field of kidney disease; providing health information in the field of kidney disease
WHERE PAIN STARTS JOURNAVX BEGINS
WHERE PAIN STARTS JOURNAVX BEGINS
Service Mark
Word
REGISTERED
Owner:
Serial:99075786
Filed:Mar 10, 2025
Classes:35, 44
Registration:8004540
Registered:Oct 28, 2025
Description: Class 35: Providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals
Class 44: Providing medical information, namely, information regarding medical conditions, treatments to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
AMKADENZ
AMKADENZ
Trademark
Word
PENDING
Owner:
Serial:99031105
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
AMKADY
AMKADY
Trademark
Word
PENDING
Owner:
Serial:99031073
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
AMKESDI
AMKESDI
Trademark
Word
PENDING
Owner:
Serial:99031086
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
AMKYDRI
AMKYDRI
Trademark
Word
PENDING
Owner:
Serial:99031079
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
ANKESDRY
ANKESDRY
Trademark
Word
PENDING
Owner:
Serial:99031093
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
APOLMEYA
APOLMEYA
Trademark
Word
PENDING
Owner:
Serial:99031096
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
KIFAMKA
KIFAMKA
Trademark
Word
PENDING
Owner:
Serial:99031102
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
LIFVOCIO
LIFVOCIO
Trademark
Word
PENDING
Owner:
Serial:99031143
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
MYVOCIO
MYVOCIO
Trademark
Word
PENDING
Owner:
Serial:99031149
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
VOCEMBLIO
VOCEMBLIO
Trademark
Word
PENDING
Owner:
Serial:99031152
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
VOCEMEO
VOCEMEO
Trademark
Word
PENDING
Owner:
Serial:99031155
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
VOCEMIVY
VOCEMIVY
Trademark
Word
PENDING
Owner:
Serial:99031163
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for treatment of cystic fibrosis
VOXFINLY
VOXFINLY
Trademark
Word
PENDING
Owner:
Serial:99031165
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
VOXJEMI
VOXJEMI
Trademark
Word
PENDING
Owner:
Serial:99031170
Filed:Feb 6, 2025
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
JOURNAVX+YOU
JOURNAVX+YOU
Service Mark
Word
REGISTERED
Owner:
Serial:99023402
Filed:Jan 30, 2025
Classes:44
Registration:8371094
Registered:Jul 28, 2026
Description: Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare
98760768
98760768
Trademark
Design
REGISTERED
Owner:
Serial:98760768
Filed:Sep 20, 2024
Classes:5
Registration:7805274
Registered:May 20, 2025
Description: Pharmaceutical preparations for the treatment of cystic fibrosis
ALYFTREK
ALYFTREK
Trademark
Combined
REGISTERED
Owner:
Serial:98760764
Filed:Sep 20, 2024
Classes:5
Registration:7805273
Registered:May 20, 2025
Description: Pharmaceutical preparations for the treatment of cystic fibrosis
TALK ABOUT PAIN
TALK ABOUT PAIN
Service Mark
Combined
REGISTERED
Owner:
Serial:98517104
Filed:Apr 24, 2024
Classes:44
Registration:7662225
Registered:Jan 21, 2025
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare; providing health information in the field of acute pain management
TALK ABOUT PAIN
TALK ABOUT PAIN
Service Mark
Word
REGISTERED
Owner:
Serial:98517101
Filed:Apr 24, 2024
Classes:44
Registration:7662224
Registered:Jan 21, 2025
Description: Providing health information to patients and caregivers; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare; providing health information in the field of acute pain management
ALYFTREK
ALYFTREK
Trademark
Word
REGISTERED
Owner:
Serial:98321063
Filed:Dec 19, 2023
Classes:5
Registration:7875259
Registered:Jul 29, 2025
Description: Pharmaceutical preparations for the treatment of cystic fibrosis
VERTEX CELL AND GENETIC THERAPIES
VERTEX CELL AND GENETIC THERAPIES
Service Mark
Word
REGISTERED
Owner:
Serial:98195949
Filed:Sep 25, 2023
Classes:42
Registration:7883674
Registered:Aug 5, 2025
Description: Medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
GPS AXIS
GPS AXIS
Service Mark
Combined
REGISTERED
Owner:
Serial:98148160
Filed:Aug 24, 2023
Classes:42, 44
Registration:7771542
Registered:Apr 22, 2025
Description: Providing health information; providing information in the fields of health and wellness; providing medical information; Providing on-line non-downloadable software for use by healthcare professionals to view and access information used in providing healthcare guidance and patient support; Providing on-line non-downloadable software to enroll patients, view patient information, manage and track prescriptions, verify patient benefits, and manage and keep track of patient treatment and program enrollment status
GPS AXIS YOUR PORTAL TO VERTEX TREATMENT MANAGEMENT
GPS AXIS YOUR PORTAL TO VERTEX TREATMENT MANAGEMENT
Service Mark
Combined
REGISTERED
Owner:
Serial:98148157
Filed:Aug 24, 2023
Classes:42, 44
Registration:7771541
Registered:Apr 22, 2025
Description: Providing health information; providing information in the fields of health and wellness; providing medical information; Providing on-line non-downloadable software for use by healthcare professionals to view and access information used in providing healthcare guidance and patient support; Providing on-line non-downloadable software to enroll patients, view patient information, manage and track prescriptions, verify patient benefits, and manage and keep track of patient treatment and program enrollment status
WALKING WITH WARRIORS
WALKING WITH WARRIORS
Service Mark
Word
REGISTERED
Owner:
Serial:98117591
Filed:Aug 4, 2023
Classes:44
Registration:7591388
Registered:Dec 3, 2024
Description: Providing health information in the field of sickle cell disease; providing health care information in the field of sickle cell disease by means of a website
JOURNAVX
JOURNAVX
Trademark
Word
REGISTERED
Owner:
Serial:98107706
Filed:Jul 28, 2023
Classes:5
Registration:7836767
Registered:Jun 17, 2025
Description: Pharmaceuticals and medicines for the treatment of pain
NAVKAYA
NAVKAYA
Trademark
Word
ABANDONED
Owner:
Serial:98107712
Filed:Jul 28, 2023
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
NAVKYOS
NAVKYOS
Trademark
Word
ABANDONED
Owner:
Serial:98107716
Filed:Jul 28, 2023
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
RAYNAVI
RAYNAVI
Trademark
Word
ABANDONED
Owner:
Serial:98107718
Filed:Jul 28, 2023
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
REKAYA
REKAYA
Trademark
Word
PENDING
Owner:
Serial:98107710
Filed:Jul 28, 2023
Classes:5
Description: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
ISLAKEY
ISLAKEY
Trademark
Word
PENDING
Owner:
Serial:98080570
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
ISLATRUVE
ISLATRUVE
Trademark
Word
PENDING
Owner:
Serial:98080572
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
ISLATYD
ISLATYD
Trademark
Word
PENDING
Owner:
Serial:98080580
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
ISLETRUVE
ISLETRUVE
Trademark
Word
PENDING
Owner:
Serial:98080575
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
IZLETYDE
IZLETYDE
Trademark
Word
PENDING
Owner:
Serial:98080579
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
ZUNISLA
ZUNISLA
Trademark
Word
PENDING
Owner:
Serial:98080582
Filed:Jul 11, 2023
Classes:5
Description: Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use
VERTEX CONNECTS
VERTEX CONNECTS
Service Mark
Stylized
REGISTERED
Owner:
Serial:97772907
Filed:Jan 30, 2023
Classes:42, 44
Registration:7329588
Registered:Mar 12, 2024
Description: Class 42: Providing online non-downloadable software featuring a portal for order management and maintaining chain of identity and chain of custody of cell therapy and genetic therapy products and medicinal applications
Class 44: Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare
VERTEX CONNECTS
VERTEX CONNECTS
Service Mark
Stylized
REGISTERED
Owner:
Serial:97772944
Filed:Jan 30, 2023
Classes:42, 44
Registration:7329589
Registered:Mar 12, 2024
Description: Class 42: Providing online non-downloadable software featuring a portal for order management and maintaining chain of identity and chain of custody of cell therapy and genetic therapy products and medicinal applications
Class 44: Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare
VERTEX CONNECTS
VERTEX CONNECTS
Service Mark
Word
REGISTERED
Owner:
Serial:97760609
Filed:Jan 19, 2023
Classes:42
Registration:7329579
Registered:Mar 12, 2024
Description: Providing online non-downloadable software featuring a portal for order management and maintaining chain of identity and chain of custody of cell therapy and genetic therapy products and medicinal applications
VERTEX CONNECTS
VERTEX CONNECTS
Service Mark
Word
REGISTERED
Owner:
Serial:97637068
Filed:Oct 18, 2022
Classes:41, 42, 44
Registration:7852340
Registered:Jul 1, 2025
Description: Class 41: Educational services, namely, providing classes, seminars, and workshops in the fields of medications, cell therapy and genetic therapy
Class 42: Providing medical and scientific research information in the field of cell therapy; providing pharmaceutical research and development in the field of cell therapy; Providing medical and scientific research information in the field of genetic therapy; providing pharmaceutical research and development in the field of genetic therapy
Class 44: Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare
97609470
97609470
Trademark
Design
REGISTERED
Owner:
Serial:97609470
Filed:Sep 27, 2022
Classes:5
Registration:7356920
Registered:Apr 9, 2024
Description: Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
NAVIGATOR BY VERTEX
NAVIGATOR BY VERTEX
Trademark
Word
ABANDONED
Owner:
Serial:97589131
Filed:Sep 13, 2022
Classes:5, 42, 44
Description: Pharmaceutical preparations for the treatment of genetic disorders; Providing health information to patients, caregivers and health care professionals; providing health care information relating to genetic disorders, medications, cell therapy and genetic therapy; Providing medical and scientific research information in the field of cell therapy; providing medical and scientific research information in the field of genetic therapy
ALYFTEO
ALYFTEO
Trademark
Word
ABANDONED
Owner:
Serial:97312640
Filed:Mar 15, 2022
Classes:5
VYKAFTY
VYKAFTY
Trademark
Word
ABANDONED
Owner:
Serial:97293767
Filed:Mar 3, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of cystic fibrosis
CTX001
CTX001
Trademark
Word
ABANDONED
Owner:
Serial:97267617
Filed:Feb 15, 2022
Classes:42
GENE POSSIBILITIES
GENE POSSIBILITIES
Service Mark
Word
REGISTERED
Owner:
Serial:97232101
Filed:Jan 21, 2022
Classes:42, 44
Registration:7057119
Registered:May 16, 2023
Description: Class 42: Providing medical and scientific research information in the field of gene editing
Class 44: Providing medical and healthcare information in the field of gene editing technology; Providing medical and healthcare information in the field of gene editing technology to health care professionals, to persons having genetic diseases, and to their caregivers
GENEPOSSIBILITIES.COM
GENEPOSSIBILITIES.COM
Service Mark
Word
ABANDONED
Owner:
Serial:97232135
Filed:Jan 21, 2022
Classes:42
CASREYO
CASREYO
Trademark
Word
ABANDONED
Owner:
Serial:97180806
Filed:Dec 20, 2021
Classes:5
Description: Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
IMMUNOTUNE
IMMUNOTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149079
Filed:Nov 30, 2021
Classes:42
Description: Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services
IMMUNOTUNE
IMMUNOTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149086
Filed:Nov 30, 2021
Classes:45
Description: Licensing of intellectual property; licensing of intellectual property in the field of hematology, biochemical processes in the blood, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases
IMMUNOTUNE
IMMUNOTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149083
Filed:Nov 30, 2021
Classes:44
Description: Providing medical information, consultancy and advisory services; providing medical information and data in the field of hematology, biochemical processes in the blood, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases
PROTUNE
PROTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149061
Filed:Nov 30, 2021
Classes:42
Description: Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services
PROTUNE
PROTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149067
Filed:Nov 30, 2021
Classes:44
Description: Providing medical information, consultancy and advisory services; providing medical information and data in the field of hematology, biochemical processes in the blood, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases
PROTUNE
PROTUNE
Service Mark
Word
ABANDONED
Owner:
Serial:97149074
Filed:Nov 30, 2021
Classes:45
Description: Licensing of intellectual property; licensing of intellectual property in the field of hematology, biochemical processes in the blood, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases
AYMVOKE
AYMVOKE
Trademark
Word
ABANDONED
Owner:
Serial:97096645
Filed:Oct 28, 2021
Classes:5
Description: Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia